Five Prime Therapeutics (FPRX) Short Interest Ratio & Short Volume → Investors Alert: The Next Big Thing in Weight Loss (From Behind the Markets) (Ad) Free FPRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Five Prime Therapeutics Short Interest DataCurrent Short Volume2,970,000 sharesPrevious Short Volume1,900,000 sharesChange Vs. Previous Month+56.32%Dollar Volume Sold Short$112.09 millionShort Interest Ratio / Days to Cover1.4Last Record DateMarch 31, 2021Outstanding Shares46,572,000 sharesPercentage of Shares Shorted6.38%Today's Trading Volume0 sharesAverage Trading Volume1,981,352 sharesToday's Volume Vs. Average0% Short Selling Five Prime Therapeutics ? Sign up to receive the latest short interest report for Five Prime Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFPRX Short Interest Over TimeFPRX Days to Cover Over TimeFPRX Percentage of Float Shorted Over Time Ad Behind the MarketsInvestors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> Five Prime Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20212,970,000 shares $112.09 million +56.3%N/A1.4 $37.74 3/15/20211,900,000 shares $71.71 million -33.3%N/A1 $37.74 2/26/20212,850,000 shares $65.78 million +10.5%N/A1.6 $23.08 2/12/20212,580,000 shares $51.39 million +3.2%N/A2.8 $19.92 1/29/20212,500,000 shares $39.68 million +11.1%N/A0.9 $15.87 1/15/20212,250,000 shares $35.91 million +11.4%N/A0.9 $15.96 Get the Latest News and Ratings for FPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Five Prime Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/20202,020,000 shares $36.87 million +77.2%N/A0.8 $18.25 12/15/20201,140,000 shares $20.01 million +26.8%N/A0.5 $17.55 11/30/2020899,400 shares $17.15 million -56.1%N/A0.4 $19.07 11/15/20202,050,000 shares $43.89 million +78.3%N/A0.9 $21.41 10/30/20201,150,000 shares $5.62 million -23.3%N/A2.6 $4.89 10/15/20201,500,000 shares $8.93 million -12.3%4.2%4.4 $5.95 9/30/20201,710,000 shares $8.04 million +3.6%4.8%5.2 $4.70 9/15/20201,650,000 shares $6.93 million -0.6%4.7%4.8 $4.20 8/31/20201,660,000 shares $7.09 million +3.1%4.7%4.1 $4.27 8/14/20201,610,000 shares $8.11 million +0.6%4.6%3.8 $5.04 7/31/20201,600,000 shares $9.44 million -5.3%4.5%3.4 $5.90 7/15/20201,690,000 shares $10.12 million No Change4.8%3.6 $5.99 6/30/20201,690,000 shares $11.32 million +6.3%4.8%3.7 $6.70 6/15/20201,590,000 shares $6.82 million +20.5%4.5%3.9 $4.29 5/29/20201,320,000 shares $6.61 million -0.8%3.7%3.8 $5.01 5/15/20201,330,000 shares $5.51 million +0.8%3.8%3.6 $4.14 4/30/20201,320,000 shares $4.33 million -5.0%3.7%3.5 $3.28 4/15/20201,390,000 shares $4.06 million +9.5%3.9%3.8 $2.92 3/31/20201,270,000 shares $2.88 million -10.7%3.6%3 $2.27 3/13/20201,422,400 shares $3.84 million -10.5%4.0%3.8 $2.70 2/28/20201,590,000 shares $3.85 million -8.1%4.5%3.3 $2.42 2/14/20201,730,000 shares $5.71 million -9.4%4.9%3.4 $3.30 1/31/20201,910,000 shares $9.23 million +11.7%5.4%4 $4.83 1/15/20201,710,000 shares $8.86 million +14.0%4.8%3.5 $5.18 12/31/20191,500,000 shares $8.36 million -4.5%4.2%3.4 $5.57 FPRX Short Interest - Frequently Asked Questions What is Five Prime Therapeutics' current short interest? Short interest is the volume of Five Prime Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 2,970,000 shares of FPRX short. Learn More on Five Prime Therapeutics' current short interest. What is a good short interest ratio for Five Prime Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FPRX shares currently have a short interest ratio of 1.0. Learn More on Five Prime Therapeutics's short interest ratio. Is Five Prime Therapeutics' short interest increasing or decreasing? Five Prime Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,970,000 shares, an increase of 56.3% from the previous total of 1,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Five Prime Therapeutics' short interest compare to its competitors? Here is how the short interest of companies compare to Five Prime Therapeutics: Catalyst Pharmaceuticals, Inc. (6.18%), Schrödinger, Inc. (8.88%), Harmony Biosciences Holdings, Inc. (21.01%), Syndax Pharmaceuticals, Inc. (11.30%), Agios Pharmaceuticals, Inc. (12.15%), Structure Therapeutics Inc. (9.92%), Evotec SE (0.02%), Amneal Pharmaceuticals, Inc. (2.51%), Edgewise Therapeutics, Inc. (9.15%), Galapagos NV (2.30%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.58 billion), Charter Communications, Inc. ($5.48 billion), Aon plc ($5.31 billion), Airbnb, Inc. ($3.01 billion), Snap Inc. ($2.99 billion), Warner Bros. Discovery, Inc. ($2.56 billion), The Kroger Co. ($2.29 billion), Expedia Group, Inc. ($2.23 billion), Peloton Interactive, Inc. ($2.19 billion), and GameStop Corp. ($2.03 billion). View all of the most shorted stocks. What does it mean to sell short Five Prime Therapeutics stock? Short selling FPRX is an investing strategy that aims to generate trading profit from Five Prime Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Five Prime Therapeutics? A short squeeze for Five Prime Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FPRX, which in turn drives the price of the stock up even further. How often is Five Prime Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FPRX, twice per month. The most recent reporting period available is March, 31 2021. More Short Interest Resources from MarketBeat Related Companies: Catalyst Pharmaceuticals Short Interest Schrödinger Short Interest Harmony Biosciences Short Interest Syndax Pharmaceuticals Short Interest Agios Pharmaceuticals Short Interest Structure Therapeutics Short Interest Evotec Short Interest Amneal Pharmaceuticals Short Interest Edgewise Therapeutics Short Interest Galapagos Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FPRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry Research